MEP39908A - Novel anticholinergic agents that can be used as medicaments and method for the production thereof - Google Patents

Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Info

Publication number
MEP39908A
MEP39908A MEP-399/08A MEP39908A MEP39908A ME P39908 A MEP39908 A ME P39908A ME P39908 A MEP39908 A ME P39908A ME P39908 A MEP39908 A ME P39908A
Authority
ME
Montenegro
Prior art keywords
medicaments
production
anticholinergic agents
novel anticholinergic
novel
Prior art date
Application number
MEP-399/08A
Other languages
Bosnian (bs)
Inventor
Helmut Meissner
Gerd Morschhaeuser
Michael Paul Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Rolf Banholzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP39908A publication Critical patent/MEP39908A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Predmetni pronalazak se odnosi na nove antiholinergike opšte formule (I) u kojoj A, X i radikali R1, R2, R3, R4, R5, R6 i R7 mogu imati ista značenja koja su navedena u patentnim zahtjevima i opisu pronalaska, na postupak za njihovo dobijanje, kao i na njihovu primjenu kao ljekovi.The present invention relates to novel anticholinergics of general formula (I) in which A, X and the radicals R1, R2, R3, R4, R5, R6 and R7 may have the same meanings as stated in the claims and the description of the invention, to a process for their obtaining, as well as on their application as drugs.

MEP-399/08A 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof MEP39908A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050994A DE10050994A1 (en) 2000-10-14 2000-10-14 New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
YUP-295/03A RS50464B (en) 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof
PCT/EP2001/011226 WO2002032899A1 (en) 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Publications (1)

Publication Number Publication Date
MEP39908A true MEP39908A (en) 2011-02-10

Family

ID=7659808

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-399/08A MEP39908A (en) 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Country Status (38)

Country Link
EP (2) EP1382606A3 (en)
JP (2) JP4109106B2 (en)
KR (1) KR100830359B1 (en)
CN (1) CN1275962C (en)
AR (1) AR035589A1 (en)
AT (1) ATE259805T1 (en)
AU (2) AU1397502A (en)
BG (1) BG66225B1 (en)
BR (1) BR0114635A (en)
CA (1) CA2425557C (en)
DE (2) DE10050994A1 (en)
DK (1) DK1325001T3 (en)
EA (1) EA005816B1 (en)
EC (1) ECSP034542A (en)
EE (1) EE05179B1 (en)
ES (1) ES2215147T3 (en)
HK (1) HK1060566A1 (en)
HR (1) HRP20030278B1 (en)
HU (1) HUP0301203A3 (en)
IL (2) IL155334A0 (en)
ME (1) MEP39908A (en)
MX (1) MXPA03003160A (en)
MY (1) MY127144A (en)
NO (1) NO328207B1 (en)
NZ (1) NZ525836A (en)
PE (1) PE20020433A1 (en)
PL (1) PL207311B1 (en)
PT (1) PT1325001E (en)
RS (1) RS50464B (en)
SA (1) SA01220414B1 (en)
SI (1) SI1325001T1 (en)
SK (1) SK287138B6 (en)
TR (1) TR200400376T4 (en)
TW (1) TWI306098B (en)
UA (1) UA73804C2 (en)
UY (1) UY26958A1 (en)
WO (1) WO2002032899A1 (en)
ZA (1) ZA200302914B (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200943A1 (en) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Process for the preparation of scopine esters
US7405224B2 (en) 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (en) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma New xanthene carboxylic acid esters, processes for their preparation and their use as medicines
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
DE10256317A1 (en) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
DE10216429A1 (en) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide
DK1497289T3 (en) * 2002-04-12 2005-10-24 Boehringer Ingelheim Pharma Drug containing betamimetics and a new anticholinergic
DE10224091A1 (en) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technical process for the production of tropenol
DE10230750A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholonergics and NK1 receptor antagonists
DE10230769A1 (en) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholinergics and PDE-IV inhibitors
ES2278170T3 (en) * 2002-07-09 2007-08-01 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO.KG PHARMACEUTICAL COMPOSITIONS OF ANTICOLINERGIC AND INHIBITORS OF QUINASE P38 IN THE TREATMENT OF RESPIRATORY DISEASES.
DE10230751A1 (en) 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug compositions based on new anticholinergics and EGFR kinase inhibitors
ES2305479T3 (en) * 2002-08-14 2008-11-01 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO.KG AEROSOL FORMULATIONS FOR INHALATION CONTAINING AN ANTI-POLINERGIC AGENT.
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (en) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (en) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
US7332175B2 (en) 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
DE10323966A1 (en) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting drug combinations for the treatment of respiratory diseases
DE10331350A1 (en) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
WO2005013999A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and a novel anticholinergic
ATE420641T1 (en) * 2003-07-28 2009-01-15 Boehringer Ingelheim Int MEDICATIONS FOR INHALATION WITH BETAMIMETICS AND AN ANTICHOLINERGIC
CA2533786A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
ATE526967T1 (en) * 2003-07-31 2011-10-15 Boehringer Ingelheim Int INHALATION MEDICATIONS CONTAINING AN ANTICHOLINERGIC AND A BETAMIMETIC
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (en) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
CA2547394A1 (en) * 2004-01-09 2005-07-28 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
CA2552903A1 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on anticholinergics and pegsunercept
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
DE102004016179A1 (en) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Compounds for the treatment of proliferative processes
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (en) * 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergic drugs for the treatment of urinary tract disorders
DE102004056578A1 (en) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaled drugs containing a new anticholinergic, formoterol and a steroid
CA2597942A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol
WO2006094924A2 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
JP2008542332A (en) * 2005-05-31 2008-11-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Novel pharmaceutical composition for the treatment of respiratory diseases
EP1898894A1 (en) * 2005-06-17 2008-03-19 Boehringer Ingelheim International GmbH Mrp iv inhibitors for the treatment of respiratory diseases
DE102005030733A1 (en) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
KR101360803B1 (en) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 Method for producing betamimetics
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055961A1 (en) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical composition containing specific concentration of quaternary ammonium anticholinergic agent, useful for treatment, by inhalation, of respiratory tract diseases
WO2008017637A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
US20080207659A1 (en) 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (en) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors.
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
WO2009010492A2 (en) * 2007-07-18 2009-01-22 Boehringer Ingelheim International Gmbh Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
EP2414560B1 (en) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Method for coating a surface of a component
WO2010133294A2 (en) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
CN102686260B (en) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
RS57740B1 (en) 2012-12-21 2018-12-31 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
CA2888431C (en) 2012-12-21 2021-10-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
ES2836977T3 (en) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizer
ES2874029T3 (en) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizer
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
UA121114C2 (en) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Nebulizer, indicator device and container
CA2952701C (en) 2014-06-18 2023-09-19 Boehringer Ingelheim Vetmedica Gmbh Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
ES2809703T3 (en) * 2015-09-04 2021-03-05 Janssen Pharmaceutica Nv Therapeutic compounds for pain and their synthesis
CN113292574B (en) * 2020-02-21 2022-05-03 四川大学 Chiral polycyclic tropane compounds, preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
TR200400376T4 (en) 2004-03-22
BG107688A (en) 2003-09-30
CN1468236A (en) 2004-01-14
EP1382606A2 (en) 2004-01-21
CA2425557C (en) 2007-11-13
EE200300151A (en) 2003-06-16
CA2425557A1 (en) 2003-04-11
HUP0301203A3 (en) 2006-05-29
AU2002213975B2 (en) 2006-11-09
UY26958A1 (en) 2002-06-20
SI1325001T1 (en) 2004-08-31
DE50101524D1 (en) 2004-03-25
ATE259805T1 (en) 2004-03-15
RS50464B (en) 2010-03-02
HUP0301203A2 (en) 2003-10-28
EP1382606A3 (en) 2004-10-13
HK1060566A1 (en) 2004-08-13
HRP20030278B1 (en) 2006-02-28
NO328207B1 (en) 2010-01-11
PE20020433A1 (en) 2002-06-28
UA73804C2 (en) 2005-09-15
JP2008120834A (en) 2008-05-29
AU1397502A (en) 2002-04-29
EE05179B1 (en) 2009-06-15
AR035589A1 (en) 2004-06-16
IL155334A0 (en) 2003-11-23
YU29503A (en) 2006-03-03
PL360673A1 (en) 2004-09-20
ZA200302914B (en) 2003-11-14
SA01220414B1 (en) 2007-01-20
DK1325001T3 (en) 2004-06-21
TWI306098B (en) 2009-02-11
PL207311B1 (en) 2010-11-30
KR100830359B1 (en) 2008-05-20
EP1325001A1 (en) 2003-07-09
EA005816B1 (en) 2005-06-30
JP4109106B2 (en) 2008-07-02
IL155334A (en) 2009-02-11
PT1325001E (en) 2004-07-30
EA200300459A1 (en) 2003-10-30
ECSP034542A (en) 2003-06-25
WO2002032899A1 (en) 2002-04-25
BR0114635A (en) 2004-02-10
NO20031693L (en) 2003-05-28
CN1275962C (en) 2006-09-20
DE10050994A1 (en) 2002-04-18
SK4352003A3 (en) 2003-08-05
ES2215147T3 (en) 2004-10-01
MXPA03003160A (en) 2005-09-09
MY127144A (en) 2006-11-30
HRP20030278A2 (en) 2005-02-28
NO20031693D0 (en) 2003-04-11
NZ525836A (en) 2004-09-24
KR20030041165A (en) 2003-05-23
EP1325001B1 (en) 2004-02-18
BG66225B1 (en) 2012-06-29
JP2004511557A (en) 2004-04-15
SK287138B6 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
MEP39908A (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
MEP58808A (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
YU4397A (en) New substituted oxazolidinones
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
ME00060B (en) Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
ME00595B (en) 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
ME00159B (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as ant-inplammatory agents
HRP20050432A2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
YU45403A (en) Novel 1,2-diphenyl azetidinones, method for producing the same medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
MEP43408A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
ECSP045159A (en) &#34;ANTAGONISTS NK1&#34;
BRPI0409716A (en) 2-acylamino-4-phenylthiazole derivatives, their preparation and their application in therapeutic
SE0104140D0 (en) Novel Compounds
RS50271B (en) Method for producing the anticholinergic agent tiotropium bromide
SE0102438D0 (en) New compounds
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
ATE372767T1 (en) DPP-IV INHIBITORS
EA200500342A1 (en) HETEROCYCLIC SUBSTITUTED PIPERASINES FOR THE TREATMENT OF SCHIZOPHRENIA
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
JO2353B1 (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MXPA02011370A (en) Substituted iminoazines.
WO2002032898A3 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
YU49195A (en) 5-membered-ring-heteroaryl-oxazolidinones, their use for the preparation of medicaments, and the medicaments containing them
BRPI0519267A2 (en) quinoline derivative, its use, production and medicine containing the same